A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
No Dimebon clinical data exist yet in patients with disease that has advanced to the
moderate-to-severe stage. Therefore, this study evaluates the safety and efficacy of Dimebon
in patients with moderate-to-severe AD who are receiving existing background therapy with
memantine.